Quantitative assessment of postoperative blood collection in brain tumor surgery under valproate medication

Zentralblatt fur Neurochirurgie

Volumn 69, Issue 4, 2008, Pages 165-169

  Psaras, Tsambika ^a   Will, B E ^a   Schoeber, W ^a   Rona, S ^a   Mittelbronn, M ^b   Honegger, J B ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Brain tumor resection; Perioperative bleeding; Valproate; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; FIBRINOGEN; HEMOGLOBIN; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD VOLUME; BRAIN SURGERY; BRAIN TUMOR; COMBINATION CHEMOTHERAPY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; DRUG WITHDRAWAL; EPILEPSY; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE PERIOD; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THERAPY EFFECT; THROMBOCYTE COUNT; TUMOR VOLUME;

ADULT; AGED; ANTICONVULSANTS; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BLOOD VOLUME; BRAIN NEOPLASMS; FEMALE; HEMORRHAGE; HUMANS; INTRAOPERATIVE COMPLICATIONS; KARNOFSKY PERFORMANCE STATUS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VALPROIC ACID;

EID: 57149094491     PISSN: 00444251     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1080939     Document Type: Article

References (21)

1. Anderson GD, Yi-Xin Lin, Berge C, Ojemann GA. Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment. J Neurosurg 1997; 87: 252-256
2. Barr RD, Copeland SA, Stockwell ML, Morris N, Kelton JC. Valproic acid and immune thrombocytopenia. Arch Dis Child 1982; 57: 681-684
3. Cheng RD, Kohrmann MH, Kerr SL et al. Thrombocytopenia associated with valproic acid that requires platelet transfusions. Ann Neurol 1989; 26: 457 (Abstract)
4. Coulter DL, Wu H, Allen RJ. Valproic acid therapy in childhood epilepsy. JAMA 1980; 244: 785-788
5. Ganick DJ, Sunder T, Finley JL. Severe hernatological toxicity of valproic acid. A report of four patients. Am J Pediatr Hematol Oncol 1990; 12: 80-85
6. Jeavons PM, Clark JE. Sodium valproate in treatment of epilepsy. Br Med J 1974; 2: 584-586
7. Kaya IS, Dilmen U, Toppare M, Senses DA, Prentice HG. Valproic acid-induced pancytopenia and coombs test positivity. Lancet 1991; 337: 1227-1228
8. Kishi T, Fujita N, Kawaguchi H, Ishimae M, Watanabe K, Tanaka T. Bone marrow suppression induced by high dose valproic acid. Arch Dis Child 1994; 71: 153-155
9. Kreuz W, Linde R, Funk M, Meyer-Schrod R, Föll E, Nowak-Göttl U, Jacobi G, Vigh Zs, Scharrer I. Valproate therapy induces von Willebrand disease Type I. Epilepsia 1992; 33: 178-184
10. Loiseau P. Sodium valproate, platelet dysfunction, and bleeding. Epilepsia 1982; 22: 122-141
11. Lundberg B, Nergårdh A, Boréus LO. Plasma concentrations of valproate during maintenance therapy in epileptic children. J Neurol 1982; 228: 133-141
12. Majer RV, Green PJ. Neonatal afibrinogenaemia due to sodium valproate. Lancet 1987; 2: 740-741
13. Nutt JG, Neophytides AN, Lodish JR. Lowered erythrocyte-sedimentation rate with sodium valproate. Lancet 1979; 2: 636 (Letter)
14. Ozkara C, Dreifuss FE, Apperson Hansen C. Changes in red blood cell with valproate therapy. Acta Neural Scand 1993; 88: 210-212
15. Pohlmann-Eden B, Peters CNA, Wennberg R, Dempfle CE. Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding. Acta Neurol Scand 2003; 108: 142-145
16. Sandier R, Emberson C, Roberts GE, Voak D, Darnborough J, Heeley AF. IgM platelet autoantibody due to sodium valproate. Br Med J 1978; 2: 1683-1684
17. Smith FR, Boots M. Sodium valproate and bone marrow suppression. Ann of Neurol 1980; 8: 197-198
18. Symon DNK, Russell G. Sodium valproate and neutropenia. Arch Dis Child 1983; 58: 235 (Letter)
19. Ward MM, Barbara NM, Laxer KD, Rampil IJ. Preoperative valproate administration does not increase blood loss during temporal lobectomy. Epilepsia 1996; 37: 98-101
20. Watts RG, Emanuel PD, Zuckerman KS, Howard TH. Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoesis. J Pediatr 1990; 117: 495-499
21. Zeller JA, Schlesinger S, Runge U, Kesslers C. Influence of valproate monotherapy on platelet activation and hematologic values. Epilepsia 1999; 40: 186-199